Quantcast

Latest Insulin-like growth factor Stories

2014-07-29 08:32:23

-Primary efficacy results on track to be received by end of August 2014 TOORAK, Australia, July 29, 2014 /PRNewswire/ -- Antisense Therapeutics Limited ("ANP") is pleased to report that dosing of all 26 patients in the Phase II trial of ATL1103 for the potentially life-threatening growth disorder, acromegaly has now been completed. There were no patient withdrawals or reports of any serious adverse events related to dosing with ATL1103. Patients will continue to be monitored for a...

2014-06-11 09:58:29

Norris Cotton Cancer Center Dartmouth researchers have found that reducing carbohydrate intake could reduce the risk of breast cancer recurrence among women whose tumor tissue is positive for the IGF-1 receptor. The study, "Risk of Breast Cancer Recurrence Associated with Carbohydrate Intake and Tissue Expression of IGFI Receptor," will appear in the July issue of Cancer Epidemiology Biomarkers & Prevention. "There is a growing body of research demonstrating associations between...

2014-03-21 12:23:50

- 24 patients now recruited into the trial TOORAK, Australia, March 21, 2014 /PRNewswire/ -- Antisense Therapeutics Limited ("ANP") is pleased to report that 24 acromegalic patients have been successfully enrolled and randomized to one of the two treatment regimens of dosing in the Phase II trial of ATL1103 for the growth disorder, acromegaly. This satisfies the necessary patient numbers proposed for the trial. Following from the positive results achieved from the interim...

2014-01-07 20:20:47

SAN FRANCISCO, Jan. 7, 2014 /PRNewswire/ -- Antisense Therapeutics Limited ("ANP" or "the Company") is pleased to advise that it has been selected to present at the Biotech Showcase 2014 conference to be held January 13-15, 2014, at The Parc 55 Wyndham Hotel in San Francisco, CA. This is a significant opportunity for ANP to present to and engage with distinguished US-based investors, prospective partners, and key industry leaders, and in particular discuss the successful progress of...

2013-11-07 13:04:41

In an article appearing in Medical Hypotheses on September 20, a New York-based physician-researcher from the Touro College of Osteopathic Medicine has called for the testing of umbilical cord blood for levels of a growth protein that could help predict an infant's propensity to later develop autism. Based on an analysis of findings in prior published studies, Touro researcher Gary Steinman, MD, PhD, proposes that depressed levels of a protein called insulin-like growth factor (IGF) could...

2013-02-03 23:03:23

AntlerX IGF-1 Deer Antler Spray Supplement meets new customer demand with a new 90 day money back guarantee on the leading deer antler velvet extract product available. Learn why AntlerX IGF-1 Spray´s risk-free 90 day refund policy makes it the best deer antler supplement available. New Orleans, Louisiana (PRWEB) February 03, 2013 In a world where body image and physical health are growing more important by the day, AntlerX´s premium IGF-1 Deer Antler Velvet Spray formula is now...

2013-01-04 11:06:52

Researchers at UNIGE analyze the impact of 3 unexpected sex determination factors So, is it a girl or a boy? This is the first question parents ask at the birth of an infant. Though the answer is obvious, the mechanism of sex determination is much less so. Researchers at the University of Geneva (UNIGE) attempt to shed light on this complex process by identifying the crucial role played by insulin and IGF1 and IGF2 growth factors, a family of hormones known for its role in metabolism and...

2012-11-27 11:25:29

Several drugs companies have ineffectively tried to produce antibodies that bind to the IGF-1 receptor on the cell surface, which has a critical part to play in the development of cancer. Scientists at Karolinska Institutet in Sweden have now ascertained how these antibodies work, and can explain why only some cancer patients are helped by IGF-1 blockers during clinical tests. The researchers also present a means by which drugs of this kind could help more cancer patients. Every cell...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related